References
- Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002;41:661–80
- Shahiwala A. Formulation approaches in enhancement of patient compliance to oral drug therapy. Expert Opin Drug Deliv 2011;8:1521–9
- Suboxone sublingual tablet, Prescribing Information. Reckitt-Benckiser Pharmaceuticals Inc.; 2012
- Suboxone sublingual film, Prescribing Information. Reckitt-Benckiser Pharmaceuticals Inc.; 2012
- Suboxone commercial webpage. Reckitt-Benckiser Inc.; 2013 Available from: http://www.suboxone.com/; http://www.suboxone.com/hcp/about_suboxone/treatment_evolution.aspx [updated 2013; last accessed 28 Jun 2013]
- Lintzeris N, Leung SY, Dunlop AJ, et al. A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug Alcohol Depend 2013;131:119–26
- Wiet SG, Beyts PK. Sensory characteristics of sucralose and other high intensity sweeteners. J Food Sci 1992;57:1014–19
- Sharma R, Soniwala M, Parikh R, Gohel M. Development of taste masked film of valdecoxib for oral use. Indian J Pharm Sci 2007;69:320–3
- Cilurzo F, Cupone IE, Minghetti P, et al. Diclofenac fast-dissolving film: suppression of bitterness by a taste-sensing system. Drug Dev Ind Pharm 2011;37:252–9
- Soottitantawat A, Takayama K, Okamura K, et al. Microencapsulation of l-menthol by spray drying and its release characteristics. Innov Food Sci Emerg Technol 2005;6:163–70
- Battu SK, Repka MA, Majumdar S, Madhusudan RY. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev Ind Pharm 2007;33:1225–32
- Fenoll-Palomares C, Munoz Montagud JV, et al. Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers. Rev Esp Enferm Dig 2004;96:773–83